Wednesday, November 7, 2018 at 12-1pm EDT. This free webinar features Andrew Morris, Sinai Healthy System, Susan Bronskill, Institute for Clinical Evaluative Sciences and Lianne Jess, St. Michael's Hospital.   They discuss how frailty has been relatively unexplored as a predictor of exposure to potentially inappropriate medications or as an effect modifier of medication-related adverse events in vulnerable populations. Quantitative and qualitative approaches were used to understand the various factors that contribute to the prescribing of PIMs and associated poor outcomes among residents living with frailty across LTC settings. Four medication classes were examined: antimicrobial, antipsychotics, cholinesterase inhibitors and anti-lipidemics. To learn more or to register click here.

Specialized Geriatric Nursing Services and Senior Friendly Care: catching up, keeping up, and leading the way in a changing era. October 10, 2018 at the Holiday Inn Yorkdale, Toronto from 8am to 4pm. This conference will be of interest to clinicians, administrators and planners in acute care hospitals, public health, community services and long-term care. To learn more or to register click here.

On August 8th, 2018 Camille Gagnon, Assistant Director of the Canadian Deprescribing Network gave this presentation to help viewers learn about which medications may not necessarily be helping patients cognitive health.  

On August 8th, 2018 Camille Gagnon, Assistant Director of the Canadian Deprescribing Network gave this presentation to help viewers learn about which medications may not necessarily be helping patients cognitive health.  

This webpage gives an overview of medication use by incarcerated women in Canada. Issues of medication access, prescribing patterns and other contextual considerations are reviewed. The use of psychotropic medications and multiple medications in this population is quite high.

The authors explored the relationship between initiation of SSRI antidepressants and completed suicide in older adults and found that there is an increased risk of suicide within the first month of therapy in comparison to the use of other antidepressants. 9 pages. Last reviewed July 2018.

Thursday, June 21, 2018 from 12-1 PM EDT. In this webinar, Dr. Barbara Farrell will highlight common elements of the deprescribing process and demonstrate approaches to engaging patients through shared decision-making. To register, click here.

Thursday, July 5th from 2-3 PM EDT. Join Dr. Tom Perry for this webinar when he will demonstrate how experienced clinicians can promote a culture shift towards deprescribing by encouraging their juniors to recognize that drug harms often exceed the potential benefits. To learn more or to register click here.

This clinical practice guideline is intended to help clincicians make decisions about when and how to safely taper and stop benzodiazepine receptor agonists (BZRAs). This guideline applies to patients who are using BZRAs to treat  primary insomnia or comorbid insomia where the potential comorbidities are effectively managed. 13 pages. Last reviewed June 2018.

September 20th from 12-1pm EST Join Nese Yuksel of the University of Alberta for this Beyond the Break OTN webcast presentation.  Event #81792801. Click here to join the live presentation. 

Pages